Indian Drug Industry Attracts Greater U.S. Scrutiny over Safety Concerns

As the Indian drug industry comes under greater scrutiny for quality lapses, U.S. regulators have called for better compliance with production standards. India is a huge supplier of prescription drugs to the U.S.   Concerns about the quality of medicines exported by India came to the forefront last year after a leading Indian drug company, Ranbaxy, pleaded guilty to falsifying clinical data and distributing adulterated medicines in the U.S.   The U.S. Food and Drug...

© La Voix de l'Amérique - vendredi 21 février 2014